BNTX NEWS: Johnson Fistel Encourages BioNTech Investors to - GlobeNewswire

Retrieved on: 2024-02-26 15:40:11

Tags for this article:

COVID-19 vaccination in the United States

Pfizer

BioNTech

Pfizer-BioNTech COVID-19 vaccine

Securities Class Action

Robbins Geller Rudman & Dowd LLP

BioNTech SE

Johnson Fistel LLP

Click the tags to see associated articles and topics

BNTX NEWS: Johnson Fistel Encourages BioNTech Investors to - GlobeNewswire. View article details on HISWAI: https://www.globenewswire.com/news-release/2024/02/26/2835264/0/en/BNTX-NEWS-Johnson-Fistel-Encourages-BioNTech-Investors-to-Seek-Counsel-Before-the-Lead-Plaintiff-Deadline.html

Excerpt

... BioNTech SE (NASDAQ: BNTX) that a securities class action lawsuit has been filed. The class action against BioNTech includes allegations that the ...

Article found on: www.globenewswire.com

View Original Article